TONMYA is now available by prescription and available for pharmacy ordering nationwideTONMYA is the first FDA-approved treatment for fibromyalgia ...

TONMYA was approved by the FDA on August 15, 2025.

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

CHATHAM, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix” or the "Company”), a fully integrated commercial biotechnology company presented data on ...

Treatment was well tolerated with minimal effects on weight or blood pressure and discontinuation rate of 19% vs. placebo of 20.8% Data support the potential of Tonmya as a well-tolerated, centrally ...

We’ve long considered Apple’s iPads to be the best tablets on the market, but determining exactly which model you should buy isn’t always straightforward. Do you just want a big screen for streaming ...

Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in NovemberTonmya is the first new FDA-approved ...

VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, ...

Tonix prepares for the November 2025 launch of Tonmya with 3Q25 revenue growth, strong cash, higher SG&A, and a robust ...

TONMYA (cyclobenzaprine HCl sublingual tablets) is a non-opioid analgesic taken once daily at bedtime for adults with fibromyalgia. The treatment was approved by the FDA on August 15, 2025, marking ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and ...

TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. If you've been searching for the perfect electronic device that ...